Previous close | 41.85 |
Open | 47.30 |
Bid | 48.00 |
Ask | 48.60 |
Strike | 230.00 |
Expiry date | 2025-01-17 |
Day's range | 47.30 - 48.20 |
Contract range | N/A |
Volume | |
Open interest | 173 |
Danaher Corporation (NYSE: DHR) (the "Company") confirmed its previously issued guidance for the third quarter and full year 2024 ahead of a previously scheduled analyst event.
We recently compiled a list of the 10 Best Cancer Stocks To Buy Now. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against the other cancer stocks. Global Oncology Market Overview and Drug Shortages In 2022, the global oncology market was valued at approximately $203.42 billion and is […]
HTHIY vs. DHR: Which Stock Is the Better Value Option?